Whatever the formal study type, someone has to keep the work moving in a controlled way once planning turns into execution. Timelines shift, sites need decisions, vendors need direction, monitoring findings need action, and small issues can become delays if nobody is holding the full picture.

Qmed provides clinical trial management for medical device and IVD studies across Europe. We take ownership of the operational control layer so clients can see what is happening, what needs escalation, and what must be solved before delivery risk grows.

What this service covers

Support can include study plans and governance, timeline control, vendor oversight, site communication, monitoring coordination, issue and deviation handling, reporting cadence, decision tracking, risk escalation, and coordination across the people delivering the study.

Some clients need a full study manager embedded as the main point of control. Others need fractional support to reinforce an internal team during periods of pressure, multi-country complexity, or rapid scale-up.

Typical situations

A common pattern is that the study is technically designed, but operational ownership is spread too thinly. Internal teams are strong in one area, but nobody is consistently connecting sites, vendors, regulatory milestones, monitoring feedback, and delivery decisions.

That gap is especially costly in European studies where local realities differ by country and timing matters. Qmed helps create one control point with clear accountability and senior judgement behind it.

Talk to Qmed

Tell us what level of trial management support you need, what’s already in place, and where operational control is under the most pressure.